Ask AI
CLAD LDAC VEN in ND AML
Phase II Trial of Cladribine + LDAC + Venetoclax Alternating With Azacitidine + Venetoclax in Patients With Newly Diagnosed AML

Released: December 13, 2024

Activity

Progress
1
Course Completed